HFY-4A is a HDAC inhibitor. HFY-4A inhibits breast cancer cell proliferation, migration, and invasion, and induces cell apoptosis.
For research use only. We do not sell to patients.
Name | HFY-4A |
---|---|
Iupac Chemical Name | (E)-N-hydroxy-3-(4-(((quinolin-2-ylmethyl)amino)methyl)phenyl)acrylamide |
Synonyms | HFY-4A; HFY 4A; HFY4A |
Molecular Formula | C20H19N3O2 |
Molecular Weight | 333.38 |
Smile | ONC(/C=C/C(C=C1)=CC=C1CNCC(C=C2)=NC3=C2C=CC=C3)=O |
InChiKey | ZZAHBOBPSBJKLS-FMIVXFBMSA-N |
InChi | InChI=1S/C20H19N3O2/c24-20(23-25)12-9-15-5-7-16(8-6-15)13-21-14-18-11-10-17-3-1-2-4-19(17)22-18/h1-12,21,25H,13-14H2,(H,23,24)/b12-9+ |
CAS Number | 2094810-82-7 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Solid powder |
---|---|
Purity | 98% Min. |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |
Yin Y, Guan X, Li G, Chen C, Duan Y, Yu Z. The HDAC inhibitor HFY-4A improves TUSC2 transcription to induce immunogenic cell death in breast cancer. Toxicol Appl Pharmacol. 2023 Nov 1;478:116698. doi: 10.1016/j.taap.2023.116698. Epub 2023 Sep 22. PMID: 37742871.